- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01827748
Evaluation of a Surgical Microscope Mounted Autorefractor When Used on Patients Lying in a Supine Position
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63131
- Ophthalmology Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Be at least 18 years of age as of the date of evaluation for the study.
Have:
- Read the Informed Consent
- been given an explanation of the Informed Consent
- indicated understanding of the Informed Consent
- signed the Informed Consent document.
- Be willing and able to adhere to the instructions set forth in this protocol and able to participate in all scheduled evaluations.
- Be in good general health, based on his/her knowledge.
- Have a refractive error within the range of -10.00 to +30.00 Diopter sphere and up to 5.00 Diopter of refractive cylinder .
- Have manifest refraction (BCVA) Snellen visual acuities (VA) equal to or better than 20/25 in each eye. -
Exclusion Criteria:
Subjects may not be enrolled in this study if any of the following apply: The subject is/has:
- Allergy to Tropicamide or a previous adverse reaction to Tropicamide.
- Poor personal hygiene as observed by the investigational site personnel.
- Strabismus
- Currently pregnant (to the best of the subject's knowledge) or is lactating.
- Previous refractive surgery or current or previous orthokeratology treatment.
- Aphakic or pseudophakic or has cataracts that interfere with visual acuity.
- Ocular or systemic disease such as, but not limited to: anterior uveitis or iritis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, sclerodermia, keratoconus or type II diabetes.
- The need for topical ocular medications or any medication which might interfere with the study evaluations.
- The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
- Slit lamp findings, including but not limited to:
Pathological dry eye or associated dry eye symptoms with decreased tear levels and punctuate staining > Grade 2 Pterygium Corneal scars within the visual axis Neovascularization or ghost vessels > 1.0 mm in from the limbus Giant papillary conjunctivitis (GPC) of > Grade 2 Anterior uveitis or iritis Seborrheic eczema, seborrheic conjunctivitis or blepharitis
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intraoperative Autorefractor IAR-1
This is a auto refractor mounted on an operating microscope.
|
This is an auto-refractor mounted on an operating microscope and used with the subject in a supine position
|
|
ACTIVE_COMPARATOR: Hartmann-Shack Auto Refractor
The Hartmann-Shack type auto refractor used with the subject sitting upright in front of the instrument.
|
Standard auto-refractor used with subject sitting upright in front of the instrument.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of the accuracy and repeatability of the Test device compared to the Control
Time Frame: 1 Hour
|
Comparative auto refractor device measurement variation is defined as +/-0.25 Diopters
|
1 Hour
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gregg Berdy, MD
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FA120928
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Myoptechs, IncUniversity of Waterloo School of Optometry and Vision ScienceNot yet recruitingMyopia: Refractive Error
-
Perfect Lens, LLCCompletedRefractive Error CorrectionPanama
-
Essilor InternationalRecruitingRefractive Error | AmetropiaUnited States
Clinical Trials on Intraoperative Autorefractor IAR-1
-
Leiden University Medical CenterCompletedCholangiocarcinoma | Pancreas AdenocarcinomaNetherlands
-
Tanta UniversityCompletedPost-Craniotomy HeadacheEgypt
-
Assistance Publique - Hôpitaux de ParisCompletedLAPAROSCOPY | Sacrum; AnomalyFrance
-
Universitätsmedizin MannheimUniversity of California, Los Angeles; Carl Zeiss Meditec AGActive, not recruitingGlioblastomaCanada, Spain, Brazil, Germany, China, United States, United Kingdom, South Korea
-
Hemerion TherapeuticsActive, not recruitingPrimary GlioblastomaUnited States, France
-
AskGene Pharma, Inc.Jiangsu Aosaikang Pharmaceutical Co., Ltd.Active, not recruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaChina
-
Idorsia Pharmaceuticals Ltd.Completed
-
Dr. Glenio Mizubuti (MD, PhD)CompletedPerioperative Tissue OxygenationCanada
-
University Health Network, TorontoRecruitingPain ManagementCanada
-
Iuliu Hatieganu University of Medicine and PharmacyCompletedAnesthesia | Neutrophil Extracellular Trap Formation | Hepato-cellular Carcinoma | Lidocaine InfusionRomania